These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease. Capell HA; Pullar T; Hunter JA Drugs; 1986; 32 Suppl 1():44-8. PubMed ID: 2877852 [TBL] [Abstract][Full Text] [Related]
3. Leucopenia during sulphasalazine treatment for rheumatoid arthritis. Marabani M; Madhok R; Capell HA; Hunter JA Ann Rheum Dis; 1989 Jun; 48(6):505-7. PubMed ID: 2568110 [TBL] [Abstract][Full Text] [Related]
4. HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment. Bliddal H; Eiberg B; Helin P; Svejgaard A Ann Rheum Dis; 1989 Jul; 48(7):539-41. PubMed ID: 2570550 [TBL] [Abstract][Full Text] [Related]
5. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Amos RS; Pullar T; Bax DE; Situnayake D; Capell HA; McConkey B Br Med J (Clin Res Ed); 1986 Aug; 293(6544):420-3. PubMed ID: 2874863 [TBL] [Abstract][Full Text] [Related]
7. Leucopenia in rheumatoid arthritis: relationship to gold or sulphasalazine therapy. Amos RS; Bax DE Br J Rheumatol; 1988 Dec; 27(6):465-8. PubMed ID: 2904830 [TBL] [Abstract][Full Text] [Related]
8. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis. Porter D; Madhok R; Hunter JA; Capell HA Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192 [TBL] [Abstract][Full Text] [Related]
9. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis. Chakravarty K; Scott DG; McCann BG Br J Rheumatol; 1992 May; 31(5):351-3. PubMed ID: 1349846 [TBL] [Abstract][Full Text] [Related]
11. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash. Bax DE; Amos RS Ann Rheum Dis; 1986 Feb; 45(2):139-40. PubMed ID: 2868699 [TBL] [Abstract][Full Text] [Related]
12. Sulphasalazine desensitisation in rheumatoid arthritis. Farr M; Scott DL; Bacon PA Br Med J (Clin Res Ed); 1982 Jan; 284(6309):118. PubMed ID: 6119134 [No Abstract] [Full Text] [Related]
13. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash. Farr M; Bacon PA Ann Rheum Dis; 1987 May; 46(5):421. PubMed ID: 2884936 [No Abstract] [Full Text] [Related]
14. Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis. Greaves M; Amos RS; Bax D Br Med J (Clin Res Ed); 1987 Feb; 294(6568):373. PubMed ID: 2880620 [No Abstract] [Full Text] [Related]
15. Psoriasis-like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy. Bliddal H; Stangerup M Clin Rheumatol; 1991 Jun; 10(2):178-80. PubMed ID: 1680596 [TBL] [Abstract][Full Text] [Related]
16. Acute alveolitis and sulphasalazine in rheumatoid arthritis. Geborek P; Monti M; Sandblad F; Wollheim FA Clin Exp Rheumatol; 1984; 2(3):279-80. PubMed ID: 6152205 [No Abstract] [Full Text] [Related]
17. Ten years of sulphasalazine use in rheumatoid arthritis. McConkey B Br J Rheumatol; 1989 Apr; 28(2):175-6. PubMed ID: 2565130 [No Abstract] [Full Text] [Related]
18. Macrocytosis and sulphasalazine treatment of rheumatoid arthritis. Ralston SH; Willocks LJ; Shaw RW; Pitkeathly DA Br J Rheumatol; 1987 Dec; 26(6):472-3. PubMed ID: 2891393 [No Abstract] [Full Text] [Related]